MEDE BLOGS

  Gleevec and Imatinib are two brand names for a medication commonly used to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). The active ingredient in both medications is imatinib, a tyrosine kinase inhibitor that works by blocking certain proteins that contribute to the growth of cancer cells. One of the concerns for many patients is the cost of these medications, which can be significant. In the United States, the average retail cost of a 30-day supply of Gleevec is around $10,000, while the average retail cost of Imatinib is around $7,000. However, the actual cost of these medications will vary depending on factors such as insurance coverage and pharmacy location. It's important to note that the cost of these medications is not the same as their price. The price is what the manufacturer sets for the medication, while the cost is what the patient pays after taking into account insurance coverage and other discounts. For example, a patient with insu...

  Imatinib, sold under the brand name Gleevec, is a prescription medication used to treat certain types of cancer, such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). While it can be an effective treatment option, the Imatinib Cost can be a concern for some patients. In this blog, we will discuss some of the factors that can influence the imatinib price and provide tips on how to manage the cost of this medication. One factor that can affect the imatinib price is the dosage strength. Imatinib is available in several dosage strengths, including 100 mg, 200 mg, and 400 mg tablets. The price of the medication will vary based on the dosage strength that is prescribed by your doctor. Another factor that can impact the Imatinib Cost is the length of treatment. Imatinib is typically taken for an extended period of time, and the longer you need to take the medication, the more expensive it may become. Insurance coverage is also an important factor to consid...